CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus
- PMID: 11358978
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus
Erratum in
- J Leukoc Biol 2001 Aug;70(2):340
Abstract
A subset of CD161 (NK1) T cells express an invariant Valpha14Jalpha281 TCR-alpha chain (Valpha(invt) T cells) and produce Th2 and Th1 cytokines rapidly in response to CD1d, but their physiological function(s) remain unclear. We have found that CD1d-reactive T cells mediate to resistance against the acute, cytopathic virus diabetogenic encephalomyocarditis virus (EMCV-D) in relatively Th1-biased, C57BL/6-based backgrounds. We show now that these results generalize to Th2-biased, hypersensitive BALB/c mice. CD1d-KO BALB/c mice were more susceptible to EMCV-D. Furthermore, alpha-galactosylceramide (alpha-GalCer), a CD1d-presented lipid antigen that specifically activates Valpha(invt) T cells, protected wild-type (WT) mice against EMCV-D-induced encephalitis, myocarditis, and diabetes. In contrast, neither CD1d-KO nor Jalpha281-KO mice were protected by alpha-GALCER: Finally, disease in Jalpha281-KO mice was comparable to WT, indicating for the first time equivalent roles for CD1d-reactive Valpha(invt) and noninvariant T cells in resistance to acute viral infection. A model for how CD1d-reactive T cells can initiate immune responses, which synthesizes current results, is presented.
Similar articles
-
Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.J Immunol. 1999 Sep 1;163(5):2373-7. J Immunol. 1999. PMID: 10452969
-
CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.J Virol. 2006 Jul;80(14):7146-58. doi: 10.1128/JVI.02745-05. J Virol. 2006. PMID: 16809320 Free PMC article.
-
Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.Cell Immunol. 2001 Aug 1;211(2):96-104. doi: 10.1006/cimm.2001.1833. Cell Immunol. 2001. PMID: 11591113
-
Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions.Semin Immunol. 2000 Dec;12(6):551-60. doi: 10.1006/smim.2000.0273. Semin Immunol. 2000. PMID: 11145861 Review.
-
CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity.Semin Immunol. 2000 Dec;12(6):537-42. doi: 10.1006/smim.2000.0276. Semin Immunol. 2000. PMID: 11145859 Review.
Cited by
-
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.Nat Commun. 2024 Feb 6;15(1):974. doi: 10.1038/s41467-024-44905-z. Nat Commun. 2024. PMID: 38321023 Free PMC article. Clinical Trial.
-
Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines.Vaccines (Basel). 2021 Aug 26;9(9):949. doi: 10.3390/vaccines9090949. Vaccines (Basel). 2021. PMID: 34579186 Free PMC article. Review.
-
Ceramide and Related Molecules in Viral Infections.Int J Mol Sci. 2021 May 26;22(11):5676. doi: 10.3390/ijms22115676. Int J Mol Sci. 2021. PMID: 34073578 Free PMC article. Review.
-
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.Blood. 2019 May 23;133(21):2291-2304. doi: 10.1182/blood-2018-10-882944. Epub 2019 Feb 22. Blood. 2019. PMID: 30796021 Free PMC article.
-
Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.J Virol. 2018 Oct 29;92(22):e01490-18. doi: 10.1128/JVI.01490-18. Print 2018 Nov 15. J Virol. 2018. PMID: 30185591 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials